Regulation of matrix metalloproteinases and effect of MMP-inhibition in heart transplant related reperfusion injury

European Journal of Cardio-thoracic Surgery

Volumn 22, Issue 1, 2002, Pages 53-58

  Falk, V ^a,b   Soccal, P M ^a   Grunenfelder J ^a   Hoyt, G ^a   Walther, T ^b   Robbins, R C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Heartcenter Leipzig ^*  (Germany)

Author keywords

Heart; Matrix metalloproteinases; Transplant

Indexed keywords

BATIMASTAT; COLLAGEN TYPE 4; GELATINASE A; GELATINASE B; LAMININ; MATRIX METALLOPROTEINASE INHIBITOR; MYELOPEROXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BASEMENT MEMBRANE; CONFERENCE PAPER; CONTROLLED STUDY; DEGRADATION; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; ISOGRAFT; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; RAT STRAIN; REPERFUSION INJURY;

ANIMALS; BASEMENT MEMBRANE; HEART TRANSPLANTATION; MALE; MATRIX METALLOPROTEINASES; METALLOENDOPEPTIDASES; MYOCARDIAL REPERFUSION INJURY; PEROXIDASE; PHENYLALANINE; RATS; RATS, INBRED STRAINS; THIOPHENES; TRANSPLANTATION, HOMOLOGOUS; TRANSPLANTATION, ISOGENEIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0036305443     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(02)00207-5     Document Type: Conference Paper

References (26)

1. The role of matrix metalloproteinases in heart disease
2. Matrix metalloproteinase synthesis and expression in isolated LV myocyte preparations
3. Myocardial matrix metalloproteinase activity and abundance with congestive heart failure
4. Matrix metalloproteinase expression in cardiac myocytes following myocardial infarction in the rabbit
5. Regression of left ventricular hypertrophy after surgical therapy for aortic stenosis is associated with changes in extracellular matrix gene expression
6. Time-dependent changes in matrix metalloproteinase - Activity and expression during progression of congestive heart failure. Relation to ventricular and myocyte function
7. Matrix metalloproteinase inhibition during the development of congestive heart failure: Effects on left ventricular dimensions and function
8. Increased expression of gelatinases and alteration of basement membrane in rat soleus muscle following femoral artery ligation
9. Early appearance of activated matrix metalloproteinase-9 and blood-brain barrier disruption in mice after focal cerebral ischemia and reperfusion
10. Matrix metalloproteinases increase very early during experimental focal cerebral ischemia
11. Matrix metalloproteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain
12. Delayed reperfusion alters matrix metalloproteinase activity and fibronectin mRNA expression in the infarct zone of the ligated rat heart
13. Increased amounts of collagenase and gelatinase in porcine myocardium following ischemia and reperfusion
14. Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice
15. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart
16. Basal lamina of rat myocardium - Its fate after death of cardiac myocytes
17. Myeloperoxidase activity as a quantitative assessment of neutrophil infiltration into ischemic myocardium
18. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decrease nitric oxide production in cirrhotic rats with portal hypertension and ascites
19. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy
20. Interleukin-1β and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro
21. Decreased expression of tissue inhibitor of metalloproteinase 1 in stunned myocardium
22. Evolution of matrix metalloproteinase and tissue inhibitor expression during heart failure progression in the infarcted rat
23. Altered expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in acutely rejected myocardium and coronary arteriosclerosis in cardiac allografts of non-human primates
24. The expression of extracellular matrix proteins during accelerated rejection of cardiac allografts in sensitized rats
25. Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure
26. MMP inhibition modulates TNF-alpha transgenic mouse phenotype early in the development of heart failure